netFormulary
 Report : A-Z of formulary items 25/10/2020 16:55:40
[Back]
 

Select a chapter:   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   20  

Chapter 10 : Musculoskeletal and joint diseases
Section Name
10.01.03 Abatacept injection 
10.01.01 Acelofenac tabs 
10.01.03 Adalimumab injection rheumatology indications
10.01.04 Allopurinol tabs 
10.01.03 Anakinra injection Adult-Onset Still's Disease
10.01.04 Anakinra injection cytokine release syndrome (CRS) or neurotoxicity after CAR-T therapy - off-label
10.01.04 restricted  Anakinra injection Polyarticular acute gout - off-label
10.01.01 Arthrotec® tabs  diclofenac + misoprostol
10.01.01 Aspirin tabs analgesia
10.01.01 Aspirin tabs pericarditis - off-label
10.01.03 Auranofin tablets 
10.01.03 Azathioprine tabs rheumatology indications - including off-label use
10.02.02 restricted  Baclofen intrathecal injection 
10.02.02 Baclofen tablets GHB withdrawal - off-label
10.02.02 Baclofen tablets, oral liquid 
10.01.03 Baricitinib tabs 
10.01.03 restricted  Belimumab injection 
10.01.04 Benzbromarone tabs 
10.03.02 Benzydamine cream  Difflam®
10.02.02 restricted  Cannabis extract oromucosal spray Sativex®
10.03.02 Capsaicin cream 0.025%
10.03.02 restricted  Capsaicin patch 8% Qutenza ®
10.01.01 Celecoxib capsules 
10.01.03 Certolizumab pegol injection 
10.01.03 Chloroquine sulphate tabs 
10.01.03 Ciclosporin caps, oral solution rheumatology indications, including off-label use
10.01.04 Colchicine tablets gout
10.03.01 restricted  Collagenase injection Xiapex® - Dupuytren’s contracture
10.01.05 restricted  Cyclophosphamide injection 
10.02.02 Dantrolene sodium caps 
10.02.02 Dantrolene sodium injection 
10.03.02 Deep Heat ® maximum strength cream dilation in capillary blood testing
10.01.02.02 Dexamethasone injection rheumatology indications
10.02.02 Diazepam tabs, injection 
10.04 Dibotermin alfa  InductOs ®
10.01.01 Diclofenac sodium e/c, m/r & disp tabs, suppositories 
10.02.01 Edrophonium chloride injection 
10.04 Eptotermin alfa implant Ossigraft ®
10.01.03 Etanercept injection rheumatology indications
10.01.01 Etoricoxib tabs 
10.01.04 Febuxostat tabs 
10.01.01 Fenbufen tabs 
10.01.01 Flurbiprofen tabs 
10.01.03 Golimumab injection rheumatology indications
10.03.01 Hyaluronic acid intra-articular injection  Ostenil®, Ostenil Plus®
10.03.01 Hyaluronidase injection 
10.01.02.02 Hydrocortisone acetate injection 
10.01.02.02 Hydrocortisone acetate injection 25mg/mL Hydrocortistab® - off-label musculoskeletal use
10.01.03 Hydroxychloroquine tabs rheumatology indications - including off-label use
10.03.01 Hylan G-F 20 intra-articular injection  Synvisc®, Synvisc-One®
10.01.01 Ibuprofen tabs pericarditis - off-label
10.03.02 Ibuprofen 5 % gel 
10.01.01 Indometacin caps, m/r caps, suppositories licensed use
10.01.01 Indometacin suppositories prophylaxis of pancreatitis post ERCP
10.01.03 Infliximab injection licensed rheumatology indications
10.01.03 restricted  Infliximab injection rheumatology off-label indications
10.01.05 restricted  Interferon alpha Behcet's Disease
10.03.02 Kaolin Poultice 
10.01.01 Ketoprofen caps 
10.03.02 Ketoprofen gel 
10.01.03 Leflunomide tabs rheumatology indications - including off-label use
10.01.02.02 Lidocaine injection 1%, 2% off-label use in conjunction with steroid injections
10.01.01 Mefenamic acid caps, tabs 
10.01.01 Meloxicam tabs 
10.01.03 Methotrexate tablets, subcutaneous injection rheumatology indications - including off-label use
10.01.02.02 Methylprednisolone acetate with lidocaine injection Depo-Medrone® with Lidocaine
10.01.02.02 Methylprednisolone acetate with lidocaine injection Depo-Medrone® with Lidocaine - off-label musculoskeletal use
10.01.02.02 Methylprednisolone acetate injection Depo-Medrone®
10.01.02.02 Methylprednisolone acetate injection Depo-Medrone® - off-label musculoskeletal use
10.02.02 Mexiletine caps congenital myotonia
10.01.03 Mycophenolate mofetil caps, tabs, suspension rheumatology indications - including off-label use
10.01.03 Mycophenolate sodium tabs rheumatology indications - including off-label use
10.01.01 restricted  Nabumetone tabs, suspension 
10.01.01 Naproxen tabs 
10.02.01 Neostigmine tabs, injection 
10.02 Nusinersen injection  
10.04 Palacos LV 40 
10.04 Palacos R 40 with gentamicin 
10.01.03 Penicillamine tabs rheumatoid athritis
10.04 Phenol liquid 80% nail bed ablation in ingrowing toenail
10.01.01 Phenylbutazone tablets 
10.01.04 Probenecid tabs 
10.01.04 Probenecid tabs penicillin augmentation in syphilis
10.02.01 Pyridostigmine bromide tabs 
10.02.02 Quinine bisulphate tabs 
10.02.02 Quinine sulphate tabs 
10.01.04 Rasburicase injection 
10.01.03 Rituximab injection rheumatology - licensed indications
10.01.03 restricted  Rituximab injection rheumatology - off-label indications
10.01.03 Rituximab injection ANCA vasculitis
10.02.01 Rituximab injection myaesthenia gravis - off-label
10.01.03 Sarilumab pre-filled pen or syringe 
10.01.03 Secukinumab injection ankylosing spondylitis & psoriatic arthritis
10.01.03 Soldium aurothomalate imjection 
10.01.03 Sulfasalazine e/c tablets rheumatology indications - including off-label use
10.01.04 Sulfinpyrazone tabs 
10.01.01 Sulindac tabs 
10.01.03 restricted  Tacrolimus caps Behcet's disease
10.01.03 Tacrolimus immediate release capsules off-label rheumatological indications
10.02.02 Tizanidine tabs 
10.01.03 Tocilizumab cytokine relsease syndrome following CAR T-cell therapy
10.01.03 Tocilizumab injection Adult-Onset Still's Disease
10.01.03 Tocilizumab injection Takayasu arteritis -off-label
10.01.03 Tocilizumab injection arthritis
10.01.03 Tocilizumab subcutaneous injection giant cell arteritis
10.01.03 Tofacitinib tabs rheumatology indications
10.01.02.02 Triamcinolone acetonide injection Kenalog® - off-label musculoskeletal use
10.01.02.02 Triamcinolone acetonide injection Adcortyl® - off-label musculoskeletal use
10.01.02.02 Triamcinolone acetonide injection  Adcortyl®
10.01.02.02 Triamcinolone acetonide injection Kenalog®
10.01.03 Ustekinumab injection psoriatic arthritis
South East London Joint Medicines Formulary